Yangtze River Pharmaceutical Group Co., Ltd.
Yangtze River Pharmaceutical Group Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2024-10-15 | NCT04912518 | |
| Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules | Cancer-related Fatigue | Not yet recruiting | Phase 4 | 2024-04-24 | NCT06381557 |